Changying Li

1.2k total citations
44 papers, 925 citations indexed

About

Changying Li is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Changying Li has authored 44 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Cancer Research and 9 papers in Surgery. Recurrent topics in Changying Li's work include Cancer-related molecular mechanisms research (9 papers), Prostate Cancer Treatment and Research (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Changying Li is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Prostate Cancer Treatment and Research (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Changying Li collaborates with scholars based in China, United States and Australia. Changying Li's co-authors include Jiwu Chang, Ming Gao, Sijin Liu, Ming Xu, Yun Liu, Hongjie Li, Ting Zhang, Min Cong, Haitao Wang and Jianmin Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Changying Li

44 papers receiving 913 citations

Peers

Changying Li
Zhijun Min China
Yong Hwa Jo South Korea
Jian Tian China
Liang Zhu China
Feifei Pu China
Ji Zhu China
Jiayi Yao China
Yu‐Zheng Ge China
Zhijun Min China
Changying Li
Citations per year, relative to Changying Li Changying Li (= 1×) peers Zhijun Min

Countries citing papers authored by Changying Li

Since Specialization
Citations

This map shows the geographic impact of Changying Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changying Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changying Li more than expected).

Fields of papers citing papers by Changying Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changying Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changying Li. The network helps show where Changying Li may publish in the future.

Co-authorship network of co-authors of Changying Li

This figure shows the co-authorship network connecting the top 25 collaborators of Changying Li. A scholar is included among the top collaborators of Changying Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changying Li. Changying Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yanyun, et al.. (2025). The Application of Traditional Chinese Medicine-Derived Formulations in Cancer Immunotherapy: A Review. Cancer Management and Research. Volume 17. 23–34. 3 indexed citations
2.
Luo, Jun, Yujing Liu, Changzhu Duan, et al.. (2023). SH2D4A inhibits esophageal squamous cell carcinoma progression through FAK/PI3K/AKT signaling pathway. Cellular Signalling. 114. 110997–110997. 3 indexed citations
3.
Li, Changying, Xiaonan Du, Zongshan Shen, et al.. (2022). The Critical and Diverse Roles of CD4–CD8– Double Negative T Cells in Nonalcoholic Fatty Liver Disease. Cellular and Molecular Gastroenterology and Hepatology. 13(6). 1805–1827. 13 indexed citations
4.
Zhang, Ying, Wei Wei, Changying Li, et al.. (2022). Idarubicin combats abiraterone and enzalutamide resistance in prostate cells via targeting XPA protein. Cell Death and Disease. 13(12). 1034–1034. 3 indexed citations
5.
Sun, Guangyong, Xinyan Zhao, Mingyang Li, et al.. (2021). CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis. Nature Communications. 12(1). 650–650. 31 indexed citations
6.
Li, Changying, Yingying Liu, Zheng Dong, et al.. (2020). TCDD promotes liver fibrosis through disordering systemic and hepatic iron homeostasis. Journal of Hazardous Materials. 395. 122588–122588. 21 indexed citations
7.
Li, Jianmin, et al.. (2020). B7-1 and GM-CSF enhance the anti-tumor immune effect of DC-tumor fusion vaccine in the treatment of prostate cancer. Medical Oncology. 37(11). 107–107. 7 indexed citations
8.
Zhang, Zheng, Tianyu Shen, Xiaoqing Li, et al.. (2019). Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer. Disease Markers. 2019. 1–10. 26 indexed citations
9.
Dong, Zheng, Changying Li, Chun‐Yang Yin, et al.. (2019). LncRNA PU.1 AS regulates arsenic-induced lipid metabolism through EZH2/Sirt6/SREBP-1c pathway. Journal of Environmental Sciences. 85. 138–146. 20 indexed citations
10.
Li, Changying, et al.. (2019). Trametinib in the treatment of multiple malignancies harboring MEK1 mutations. Cancer Treatment Reviews. 81. 101907–101907. 37 indexed citations
11.
Wang, Jianan, et al.. (2019). Silencing TTK expression inhibits the proliferation and progression of prostate cancer. Experimental Cell Research. 385(1). 111669–111669. 31 indexed citations
12.
Du, E, Changwen Zhang, Kuo Yang, et al.. (2017). Low expression of TMEM67 is a critical predictor of poor prognosis in human urothelial carcinoma of the bladder. Urologic Oncology Seminars and Original Investigations. 35(4). 152.e7–152.e12. 1 indexed citations
13.
Du, E, Lin Wang, Changying Li, et al.. (2017). Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer. OncoTargets and Therapy. Volume 10. 2561–2567. 11 indexed citations
14.
Li, Changying, Hongjie Li, Ting Zhang, et al.. (2014). Discovery of Apo-A1 as a potential bladder cancer biomarker by urine proteomics and analysis. Biochemical and Biophysical Research Communications. 446(4). 1047–1052. 59 indexed citations
15.
Zhang, Ting, Jingyao Wang, Xiaofeng Zhai, et al.. (2014). MiR-124 retards bladder cancer growth by directly targeting CDK4. Acta Biochimica et Biophysica Sinica. 46(12). 1072–1079. 39 indexed citations
16.
Jiang, Xingkang, Shimiao Zhu, Guowei Feng, et al.. (2013). Is an Initial Saturation Prostate Biopsy Scheme Better than an Extended Scheme for Detection of Prostate Cancer? A Systematic Review and Meta-analysis. European Urology. 63(6). 1031–1039. 28 indexed citations
17.
Shi, Linping, Hanjian Du, Bing Xie, et al.. (2012). Reduced white matter integrity in primary open-angle glaucoma: A DTI study using tract-based spatial statistics. Journal of Neuroradiology. 40(2). 89–93. 32 indexed citations
18.
Zhang, Zongwang, et al.. (2011). Technical Aspects of Anesthesia and Cardiopulmonary Bypass in Patients Undergoing Totally Thoracoscopic Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia. 26(2). 270–273. 8 indexed citations
19.
20.
Li, Changying, et al.. (2008). The distribution of killer immunoglobulin-like receptor genes in Qingdao Han population. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhijun Min Breakdown of academic impact, for papers by Yong Hwa Jo Breakdown of academic impact, for papers by Jian Tian Breakdown of academic impact, for papers by Liang Zhu Breakdown of academic impact, for papers by Feifei Pu Breakdown of academic impact, for papers by Ji Zhu Breakdown of academic impact, for papers by Jiayi Yao Breakdown of academic impact, for papers by Yu‐Zheng Ge
Rankless by CCL
2026